Breast density in women with premature ovarian failure using hormone therapy.

about

ESHRE Guideline: management of women with premature ovarian insufficiency.Hormone replacement therapy in pre-menopausal women undergoing bilateral salpingo-oophorectomy for benign disease: A review of practice.

P2860

Q38786469-046577F7-AFFE-408D-A65A-15165C1E4169 Q39321977-6CC9DBD4-3BF8-4D04-9135-792A004C2930

P2860

Breast density in women with premature ovarian failure using hormone therapy.

Item

http://www.wikidata.org/entity/Q46788277

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Breast density in women with premature ovarian failure using hormone therapy.

@en

Breast density in women with premature ovarian failure using hormone therapy.

@nl

type

Item

label

Breast density in women with premature ovarian failure using hormone therapy.

@en

Breast density in women with premature ovarian failure using hormone therapy.

@nl

prefLabel

Breast density in women with premature ovarian failure using hormone therapy.

@en

Breast density in women with premature ovarian failure using hormone therapy.

@nl

P1476

Breast density in women with premature ovarian failure using hormone therapy.

@en

P2093

Carlos Alberto Petta

http://www.w3.org/2001/XMLSchema#string

Cristina Laguna Benetti-Pinto

http://www.w3.org/2001/XMLSchema#string

César Cabello Dos Santos

http://www.w3.org/2001/XMLSchema#string

Luís Alberto Magna

http://www.w3.org/2001/XMLSchema#string

Patrícia Magda Soares

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

Vasomotor flushes in menopausal women.

Factors associated with early menopause.

Recent concerns surrounding HRT.

Hormones and mammographic breast density.

Mammographic breast density as an intermediate phenotype for breast cancer.

Epidemiologic aspects of early menopause and ovarian cancer.

The effect of low dose hormone therapy on mammographic breast density.

P304

40-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09637480701690543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18224543

http://www.w3.org/2001/XMLSchema#string

Breast density in women with premature ovarian failure using hormone therapy.

about

P2860

P2860

Breast density in women with premature ovarian failure using hormone therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698